Cargando…
Immunogenicity and safety of primary fractional-dose yellow fever vaccine in autoimmune rheumatic diseases
BACKGROUND: Brazil faced a yellow fever(YF) outbreak in 2016–2018 and vaccination was considered for autoimmune rheumatic disease patients(ARD) with low immunosuppression due to YF high mortality. OBJECTIVE: This study aimed to evaluate, prospectively for the first time, the short-term immunogenicit...
Ejemplares similares
-
Ankylosing spondylitis and psoriatic arthritis: revisiting screening of latent tuberculosis infection and its follow-up during anti-tumor necrosis factor therapy in an endemic area
por: Shimabuco, Andrea Yukie, et al.
Publicado: (2020) -
Sjögren’s syndrome and systemic lupus erythematosus: links and risks
por: Pasoto, Sandra Gofinet, et al.
Publicado: (2019) -
Yellow fever vaccination in Brazil: Short-term safety and immunogenicity in juvenile autoimmune rheumatic diseases
por: Emi Aikawa, Nádia, et al.
Publicado: (2021) -
IL-23/Th17 axis is not influenced by TNF-blocking agents in ankylosing spondylitis patients
por: Milanez, Fernanda Manente, et al.
Publicado: (2016) -
Reflections on the prevalence of human leukocyte antigen-B27 and human leukocyte antigen-B51 co-occurrence in patients with spondylarthritis
por: Gonçalves Júnior, Jucier, et al.
Publicado: (2022)